Michaela Tencerová

Dr. Michaela Tencerová


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Cell Metabolism
Verified
Journal Article
Closed access
SAShinya U. Amano
Shinya U. Amano
JCJessica L. Cohen
Jessica L. Cohen
PVPranitha Vangala
Pranitha Vangala
MTMichaela Tencerová
Michaela Tencerová
SNSarah M. Nicoloro
Sarah M. Nicoloro
MAMyriam Aouadi
Myriam Aouadi

14 February 2018 in Journal of Bone and Mineral Research
Verified
Journal Article
Open access
PDF file
MTMichaela Tencerová
Michaela Tencerová
FFFlorence Figeac
Florence Figeac
NDNicholas Ditzel
Nicholas Ditzel
HTHanna Taipaleenmäki
Hanna Taipaleenmäki
TNTina Kamilla Nielsen
Tina Kamilla Nielsen
MKMoustapha Kassem
Moustapha Kassem
Obesity represents a risk factor for development of insulin resistance and Type 2 Diabetes. In addition, it has been associated with increased adipocyte formation in the bone marrow (BM) along with increased risk for bone fragility fractures. However, little is known on the cellular mechanisms that link obesity, BM adiposity and bone fragility. Thus, in an obesity intervention study in C57BL/6J mice fed with high fat diet (HFD) for 12 weeks, we investigated the molecular and cellular phenotype of bone marrow adipose tissue (BMAT), BM progenitor cells and BM microenvironment in comparison to peripheral adipose tissue (AT). HFD decreased trabecular bone mass by 29%, cortical thickness by 5% and increased BM adiposity by 184%. In contrast to peripheral AT, BMAT did not exhibit pro-inflammatory phenotype. BM progenitor cells isolated from HFD mice exhibited decreased mRNA levels of inflammatory genes (Tnfα, IL1β, Lcn2) and did not manifest an insulin resistant phenotype evidenced by normal levels of pAKT following insulin stimulation as well as normal levels of insulin signaling genes. In addition, BM progenitor cells manifested enhanced adipocyte differentiation in HFD condition. Thus, our data demonstrate that BMAT expansion in response to HFD exerts a deleterious effect on the skeleton. Continuous recruitment of progenitor cells to adipogenesis leads to progenitor cell exhaustion, decreased recruitment to osteoblastic cells and decreased bone formation. In addition, the absence of insulin resistance and inflammation in the BM suggest that BMAT buffers extra energy in the form of triglycerides and thus plays a role in whole body energy homeostasis. This article is protected by copyright. All rights reserved

27 February 2013 in Diabetologia
Verified
Journal Article
Open access
PDF file
MCM. P. Czech
M. P. Czech
MTMichaela Tencerová
Michaela Tencerová
DPD. J. Pedersen
D. J. Pedersen
MAM. Aouadi
M. Aouadi
Insulin signalling is uniquely required for storing energy as fat in humans. While de novo synthesis of fatty acids and triacylglycerol occurs mostly in liver, adipose tissue is the primary site for triacylglycerol storage. Insulin signalling mechanisms in adipose tissue that stimulate hydrolysis of circulating triacylglycerol, uptake of the released fatty acids and their conversion to triacylglycerol are poorly understood. New findings include (1) activation of DNA-dependent protein kinase to stimulate upstream stimulatory factor (USF)1/USF2 heterodimers, enhancing the lipogenic transcription factor sterol regulatory element binding protein 1c (SREBP1c); (2) stimulation of fatty acid synthase through AMP kinase modulation; (3) mobilisation of lipid droplet proteins to promote retention of triacylglycerol; and (4) upregulation of a novel carbohydrate response element binding protein β isoform that potently stimulates transcription of lipogenic enzymes. Additionally, insulin signalling through mammalian target of rapamycin to activate transcription and processing of SREBP1c described in liver may apply to adipose tissue. Paradoxically, insulin resistance in obesity and type 2 diabetes is associated with increased triacylglycerol synthesis in liver, while it is decreased in adipose tissue. This and other mysteries about insulin signalling and insulin resistance in adipose tissue make this topic especially fertile for future research.

4 March 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
ARAlexander Rauch
Alexander Rauch
AHAnders K. Haakonsson
Anders K. Haakonsson
JMJesper Grud Skat Madsen
Jesper Grud Skat Madsen
MLMette Larsen
Mette Larsen
IFIsabel Forss
Isabel Forss
SMSusanne Mandrup
Susanne Mandrup

29 April 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MAMyriam Aouadi
Myriam Aouadi
MTMichaela Tencerová
Michaela Tencerová
PVPranitha Vangala
Pranitha Vangala
JYJoseph C. Yawe
Joseph C. Yawe
SNSarah M. Nicoloro
Sarah M. Nicoloro
MCMichael P. Czech
Michael P. Czech
Adipose tissue (AT) inflammation and infiltration by macrophages is associated with insulin resistance and type 2 diabetes in obese humans, offering a potential target for therapeutics. However, whether AT macrophages (ATMs) directly contribute to systemic glucose intolerance has not been determined. The reason is the lack of methods to ablate inflammatory genes expressed in macrophages specifically localized within AT depots, leaving macrophages in other tissues unaffected. Here we report that i.p. administration of siRNA encapsulated by glucan shells in obese mice selectively silences genes in epididymal ATMs, whereas macrophages within lung, spleen, kidney, heart, skeletal muscle, subcutaneous (SubQ) adipose, and liver are not targeted. Such administration of GeRPs to silence the inflammatory cytokines TNF-α or osteopontin in epididymal ATMs of obese mice caused significant improvement in glucose tolerance. These data are consistent with the hypothesis that cytokines produced by ATMs can exacerbate whole-body glucose intolerance.

1 May 2019 in Cell Reports
Verified
Journal Article
Open access
MTMichaela Tencerová
Michaela Tencerová
MFMorten Frost
Morten Frost
FFFlorence Figeac
Florence Figeac
TNTina Kamilla Nielsen
Tina Kamilla Nielsen
DADalia Ali
Dalia Ali
MKMoustapha Kassem
Moustapha Kassem
Obesity is associated with increased risk for fragility fractures. However, the cellular mechanisms are unknown. Using a translational approach combining RNA sequencing and cellular analyses, we investigated bone marrow stromal stem cells (BM-MSCs) of 54 men divided into lean, overweight, and obese groups on the basis of BMI. Compared with BM-MSCs obtained from lean, obese BM-MSCs exhibited a shift of molecular phenotype toward committed adipocytic progenitors and increased expression of metabolic genes involved in glycolytic and oxidoreductase activity. Interestingly, compared with paired samples of peripheral adipose tissue-derived stromal cells (AT-MSCs), insulin signaling of obese BM-MSCs was enhanced and accompanied by increased abundance of insulin receptor positive (IR+) and leptin receptor positive (LEPR+) cells in BM-MSC cultures. Their hyper-activated metabolic state was accompanied by an accelerated senescence phenotype. Our data provide a plausible explanation for the bone fragility in obesity caused by enhanced insulin signaling leading to accelerated metabolic senescence of BM-MSCs.